Imaging liver tumors to predict treatment response
Part of Cancer clinical trials.
This study uses a special MRI scan with a substance called pyruvate to see how liver cancer tumors are using energy. The goal is to find out if this scan can predict how well treatment will work and help guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with liver cancer (hepatocellular carcinoma) at a stage that is considered treatable (BCLC stage A, B, or C).
- You are able to have an MRI (no metal implants in your liver, no prior reaction to MRI contrast, and you can lie still for about 1 hour).
- You have not had prior treatment (like radiation, ablation, or chemotherapy) for the specific tumor being studied.
- Your blood pressure is in a safe range, and you do not have severe heart or kidney problems.
- If you are a woman who could become pregnant, you must not be pregnant or breastfeeding, and you will need a pregnancy test.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of MRI scan (hyperpolarized 13C-MRI) in people with liver cancer who are already receiving radiation therapy, atezolizumab (an immunotherapy), and bevacizumab (a targeted therapy). The goal is to see if the scan can help doctors better understand how the cancer responds to treatment.
This early-phase study tests whether a special MRI scan with injected labeled “pyruvate” can act as a biomarker (a measurable sign) for advanced solid tumor activity. It may help doctors see tumor metabolism over time and better track how treatment is affecting cancer.
This study tests a new type of MRI that can look at the liver in more detail. It compares images from people with liver cancer and healthy people to see if it can help doctors better understand or detect the disease.
This trial tests a new imaging technique that may help doctors see liver cancer more clearly. It uses a special tracer that targets a protein found on many liver cancer cells. This could help with diagnosis and monitoring.
This study uses a special MRI scan using “hyperpolarized” labeled pyruvate (a sugar-like substance) to see how prostate cancer may be behaving in people who are on active surveillance. It may help researchers monitor cancer without immediate treatment, by spotting changes earlier.
This study tests a new imaging method that uses a special substance to find liver cancer cells. It may help doctors see if the cancer has come back after treatment, which could guide next steps.
Hear when a new Barcelona Clinic Liver Cancer (BCLC) Stage A, B or C HCC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.